Results 191 to 200 of about 2,886,262 (322)
ABSTRACT Background Neurodegeneration with brain iron accumulation (NBIA) comprises a genetically and clinically heterogeneous group of rare neurological disorders characterized particularly by iron accumulation in the basal ganglia. To date, 15 genes have been associated with NBIA.
Seda Susgun +95 more
wiley +1 more source
Introduction to the Special Issue "Understanding Brain Disease with Live Imaging". [PDF]
Bauer AQ, Nishimura N, Iordanova B.
europepmc +1 more source
Update on Nonhuman Primate Models of Brain Disease and Related Research Tools. [PDF]
Qiao N, Ma L, Zhang Y, Wang L.
europepmc +1 more source
Clinical Characteristics and Outcomes of Early‐Onset Versus Late‐Onset LGI1‐Antibody Encephalitis
ABSTRACT Background Leucine‐rich glioma‐inactivated 1 antibody (LGI1‐Ab) encephalitis predominantly affected older individuals, but has also been reported in younger patients. However, the demographic, clinical, and prognostic characteristics of early‐onset LGI1‐Ab encephalitis have yet to be systematically elucidated. This study aims to systematically
Yu Kong +7 more
wiley +1 more source
Editorial: Oligodendrocytes: from their development to function and dysfunction
Shingo Miyata, Hiroaki Wake
doaj +1 more source
ABSTRACT Background Apolipoprotein ε4 (APOE ε4) is a potent genetic risk factor for Alzheimer's disease (AD). However, its role in cerebral small vessel disease (CSVD) remains unclear. Given the clinical and pathological similarities between CSVD and AD, this study aimed to investigate the associations of APOE ε4 gene dosage with cognitive function and
Tingru Jin +6 more
wiley +1 more source
A hypergraph transformer method for brain disease diagnosis. [PDF]
Han X, Feng J, Xu H, Du S, Li J.
europepmc +1 more source
Special Issue "Mitochondria and Brain Disease". [PDF]
Cardoso S.
europepmc +1 more source
ABSTRACT Background There is growing recognition of the potential of plasma proteomics for Alzheimer's Disease (AD) risk assessment and disease characterization. However, differences between proteomics platforms introduce uncertainties regarding cross‐platform applicability.
Manyue Hu +9 more
wiley +1 more source
Fingerprints of brain disease: connectome identifiability in Alzheimer's disease. [PDF]
Stampacchia S +14 more
europepmc +1 more source

